Huiling Zhou

806 total citations
31 papers, 574 citations indexed

About

Huiling Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huiling Zhou has authored 31 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huiling Zhou's work include Nanoplatforms for cancer theranostics (6 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Huiling Zhou is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Huiling Zhou collaborates with scholars based in China, United States and Germany. Huiling Zhou's co-authors include Dongsheng Tang, Yingjie Yu, Haihua Xiao, Haihua Xiao, Xing Wang, Johannes Karges, Bin Wang, Lingpu Zhang, Minhui Cui and Hanchen Zhang and has published in prestigious journals such as Advanced Materials, Nature Communications and Science Advances.

In The Last Decade

Huiling Zhou

27 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiling Zhou China 13 236 181 107 99 94 31 574
Jingbo Ma China 16 244 1.0× 196 1.1× 104 1.0× 77 0.8× 60 0.6× 34 526
Zhengsheng Liu China 20 148 0.6× 274 1.5× 120 1.1× 63 0.6× 74 0.8× 49 1.1k
Zheng Pan China 10 229 1.0× 227 1.3× 150 1.4× 75 0.8× 68 0.7× 28 764
Yikai Han China 8 274 1.2× 112 0.6× 59 0.6× 94 0.9× 98 1.0× 12 581
Li‐Xing Yang Taiwan 15 278 1.2× 267 1.5× 227 2.1× 205 2.1× 69 0.7× 24 769
Dan Lü China 19 290 1.2× 388 2.1× 109 1.0× 95 1.0× 55 0.6× 61 979
Muzhou Teng China 14 141 0.6× 196 1.1× 70 0.7× 90 0.9× 57 0.6× 32 527
Parinaz Fathi United States 17 394 1.7× 299 1.7× 246 2.3× 84 0.8× 50 0.5× 28 864
Weixi Jiang China 15 261 1.1× 137 0.8× 104 1.0× 71 0.7× 63 0.7× 22 574
Miao Su China 12 169 0.7× 187 1.0× 68 0.6× 74 0.7× 95 1.0× 44 590

Countries citing papers authored by Huiling Zhou

Since Specialization
Citations

This map shows the geographic impact of Huiling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Zhou more than expected).

Fields of papers citing papers by Huiling Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Zhou. The network helps show where Huiling Zhou may publish in the future.

Co-authorship network of co-authors of Huiling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huiling Zhou. A scholar is included among the top collaborators of Huiling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiling Zhou. Huiling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuqian, et al.. (2025). Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer. Experimental Hematology and Oncology. 14(1). 114–114. 1 indexed citations
2.
Zhang, Yanping, et al.. (2025). MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 17(4). 102084–102084. 1 indexed citations
3.
Wang, Xixi, Huiling Zhou, Huan Xu, et al.. (2024). Targeted and non-targeted proteomics to identify the urinary protein biomarkers for Wilson disease. Clinica Chimica Acta. 567. 120090–120090.
4.
5.
Han, Rui, et al.. (2024). Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy. International Journal of Nanomedicine. Volume 19. 4803–4834. 12 indexed citations
6.
Zhou, Huiling, Dongsheng Tang, Yingjie Yu, et al.. (2023). Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway. Nature Communications. 14(1). 5350–5350. 81 indexed citations
7.
Zhou, Huiling, Wentao Jia, Lingeng Lu, & Rui Han. (2023). MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment. Cancers. 15(3). 824–824. 13 indexed citations
8.
9.
Wei, Wen-Fei, Huiling Zhou, Peiyu Chen, et al.. (2023). Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells. Journal of Experimental & Clinical Cancer Research. 42(1). 160–160. 26 indexed citations
10.
Tang, Dongsheng, Huiling Zhou, Minhui Cui, et al.. (2023). NIR‐II Light Accelerated Prodrug Reduction of Pt(IV)‐Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo‐Immunotherapy. Advanced Materials. 35(28). e2300048–e2300048. 54 indexed citations
11.
Wang, Zhe, Lin Mu, Feng He, et al.. (2022). Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models. Frontiers in Genetics. 13. 993322–993322. 3 indexed citations
12.
Zhu, Yun, et al.. (2022). Atopic Dermatitis and Skin Cancer Risk: A Systematic Review. Dermatology and Therapy. 12(5). 1167–1179. 14 indexed citations
13.
14.
He, Juan, Yi‐Qun Kuang, Hongbin Li, et al.. (2021). A Reliable Murine Model of Disseminated Infection Induced by Talaromyces Marneffei. Mycopathologia. 187(1). 53–64. 7 indexed citations
15.
Chen, Xi, et al.. (2021). The Impact on Blood Pressure of a Short-Term Change in Indoor Temperature. International Journal of General Medicine. Volume 14. 1507–1511. 3 indexed citations
16.
Zhang, Teng, Jingwei Gu, Xiangyu Liu, et al.. (2020). Bactericidal and antifouling electrospun PVA nanofibers modified with a quaternary ammonium salt and zwitterionic sulfopropylbetaine. Materials Science and Engineering C. 111. 110855–110855. 51 indexed citations
17.
Zhang, Xiubing, Hua Lu, Fengbo Zhao, et al.. (2016). Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma. Oncology Reports. 36(6). 3456–3464. 36 indexed citations
18.
Cui, Xiaopeng, Zhipeng Lin, Yuyan Chen, et al.. (2016). Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma. Molecular and Cellular Biochemistry. 421(1-2). 127–137. 36 indexed citations
19.
Lin, Zhipeng, Baoying Hu, Wenkai Ni, et al.. (2016). Expression pattern of BCCIP in hepatocellular carcinoma is correlated with poor prognosis and enhanced cell proliferation. Tumor Biology. 37(12). 16305–16315. 6 indexed citations
20.
Kreutz, Reinhold, et al.. (2008). Primärer Hyperreninismus: Eine seltene Ursache der sekundären arteriellen Hypertonie. DMW - Deutsche Medizinische Wochenschrift. 118(31). 1110–1114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingbo Ma Breakdown of academic impact, for papers by Zhengsheng Liu Breakdown of academic impact, for papers by Zheng Pan Breakdown of academic impact, for papers by Yikai Han Breakdown of academic impact, for papers by Li‐Xing Yang Breakdown of academic impact, for papers by Dan Lü Breakdown of academic impact, for papers by Muzhou Teng Breakdown of academic impact, for papers by Parinaz Fathi Breakdown of academic impact, for papers by Weixi Jiang Breakdown of academic impact, for papers by Miao Su
Rankless by CCL
2026